• von Willebrand factor-binding protein (vWbp) mediates adhesion of S. aureus under flow to activated ECs and the subendothelium via VWF.
Introduction
Staphylococcus aureus (S. aureus) is the most frequent cause of life-threatening bloodstream infections 1 . S. aureus sepsis carries a poor prognosis, with a fatal outcome in about one out of five cases 2, 3 . A major determinant of this adverse outcome is its propensity to generate secondary sites of infection upon spreading through the bloodstream 3 . In order to establish these metastatic infections and infective endocarditis in particular, circulating pathogens require a mechanism to adhere to the blood vessel wall and to overcome the shear stress of flowing blood.
Activation of endothelial cells (ECs) triggers the release of ultra-large von Willebrand factor (VWF) multimers that are temporarily retained on the EC surface. Furthermore, upon EC damage, circulating VWF binds to collagen fibers from the exposed subendothelial matrix 4 .
Vessel wall-bound VWF recruits platelets to sites of EC damage or activation through the sheardependent interaction between the platelet glycoprotein GPΙbα and the VWF A1-domain that is exposed after unfolding of VWF multimers by flowing blood 5 . A recent study revealed that S.
aureus may employ a similar VWF-dependent mechanism to adhere to ECs under shear stress 6 .
However, the bacterial factors involved in the S. aureus-VWF interactions remained to be elucidated.
A number of S. aureus proteins were shown to bind to VWF, including staphylococcal protein A (SpA) and the von Willebrand factor-binding protein (vWbp) 7 . However, the relevance of VWF as a ligand for vWbp was questioned in subsequent studies 8, 9 , and the role of vWbp-VWF interaction has not yet been studied in relevant disease models.
Nevertheless, vWbp has been shown to contribute to S. aureus pathophysiology by its ability to induce blood clotting. This coagulase activity, which differentiates S. aureus from less virulent coagulase-negative staphylococci, is the result of the conformational activation of prothrombin by two secreted proteins: staphylocoagulase (Coa) 10, 11 and vWbp 4 .
Staphylothrombin, the resulting complex of a bacterial coagulase and host prothrombin, converts fibrinogen into insoluble fibrin 11 . Because of the direct activation of prothrombin, S. aureusmediated activity is insensitive to most anticoagulant drugs, which has hampered the study of coagulase activity as a virulence factor. However, the generation of mutant strains that lack vWbp, Coa, or both, and the recent finding that the direct thrombin inhibitor dabigatran effectively inhibits S. aureus-mediated coagulation has allowed to demonstrate the contribution of this pathogen-induced clot formation to the virulence of S. aureus in local infections as well as in sepsis [12] [13] [14] [15] [16] . Furthermore, staphylothrombin-generated fibrin was shown to promote interaction between S. aureus and platelets via the platelet fibrinogen receptor
, and contributes to the initiation and propagation of experimental infective endocarditis lesions in flowing blood 14 .
In this study, we have investigated the role of both vWbp functions, VWF binding and prothrombin activation, for the adhesion of S. aureus to activated ECs and to subendothelial matrix under shear stress. We further evaluated the role of platelets in S. aureus-vessel wall adhesion focussing on the role of the platelet fibrinogen receptor
, and present a model for the endovascular dissemination of S. aureus based on VWF-vWbp-S. aureus interactions, reinforced by coagulase activity and bacteria-fibrin-platelet interactions.
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Materials and Methods

Bacterial strains
The reference strain used in this study is S. aureus Newman, originally isolated from a case of osteomyelitis, with a well-described profile of coagulase activity 12, 16 . The isogenic single and double coagulase-deficient mutants S. aureus Newman vwb, coa and coa/vwb with complementing plasmid have been described 16 . The double coagulase-deficient mutant has no detectable coagulase activity, i.e. is not able to activate host's prothrombin and generate fibrin.
Bacteria were fluorescently labeled with 5(6)-carboxy-fluorescein-N-hydroxysuccinimidyl ester (Sigma-Aldrich, Germany). Recombinant His 6 -vWbp without the signal sequence and lacking coagulase activity was cloned using plasmid pET15 and purified from E. coli BL21(DE3) using
Ni-trilotriacetic acid (Ni-NTA) chromatography as previously described 16 .
In vitro perfusion experiments
Glass coverslips (24x50 mm, VWR International, Belgium) were coated with 50 
Bacterial adhesion to ECs
Human umbilical vein endothelial cells (HUVECs) were seeded on coverslips and mounted in a micro-parallel flow chamber. The ECs were activated via perfusion with 0.1 mM Ca 2+ -ionophore A23187 (Sigma-Aldrich, Germany) for 10 minutes, followed by a perfusion for 10 minutes with fluorescently labeled bacteria (OD 600 1.2). Bacterial rolling and adhesion were monitored via video-microscopic imaging, as described above.
In vivo mesenteric perfusion model
The mouse mesenteric perfusion model was used to study real-time bacterial adhesion to the vascular bed in wild type Vwf +/+ and homozygous Vwf -/-C57Bl/6 mice. Six-to eight-week old mice were anesthetized using ketamine/xylazine intraperitoneally and the right jugular vein was catheterized (Portex intravenous cannula, 2F). The peritoneal cavity was opened via midline abdominal incision to visualize the mesenteric arteriolar and venular circulation under an inverted microscope (Axio-observer D1). Following topical application of 5µL of the Ca 2+ -ionophore A23187 (10 mM) to trigger ECs activation and VWF-release, 300 µL of a suspension of labeled bacteria (OD 600 1.8, corresponding to approximately 1x10 9 CFU/mL) was injected through the jugular catheter. Where indicated, bacterial inoculation was preceded by a bolus of 50 µL of dabigatran (10 µM). Time-lapse images were acquired via online video-microscopy for analysis.
The fluorescent signal in the blood vessel was quantified manually for each frame and reported as AFU. Animal experiments were approved by the Ethical Committee of the University of Leuven.
Statistical analysis
All calculations were done using GraphPad Prism 5.0d (GraphPad Software, San Diego California USA). Groups were compared using the one-way ANOVA or a two-tailed Student's ttest. All values are reported as mean ± standard error of the mean (SEM). A P-value of < 0.05 was considered significant (* P < 0.05; ** P < 0.01; *** P < 0.001).
Results
vWbp-VWF interactions mediate S. aureus adhesion under flow
First, we assessed the adhesion of S. aureus Newman (WT) to surface-bound VWF under static and flow conditions. Adhesion of S. aureus to VWF increased with increasing shear rates ( Fig 1A, Fig S1A-B) . In contrast, adhesion of the vWbp-deficient mutant strain (vwb) remained low at all shear rates, and further decreased with increasing shear (Fig 1A) .
Reconstitution of vWbp expression restored the adhesive phenotype, confirming that vWbp is required for the shear-dependent increase in adhesion of S. aureus to VWF (Fig S2A) .
Furthermore, the addition of exogenous vWbp increased the adhesion of vwb to VWF under flow (Fig S3A-C) . Preperfusion of the coated VWF with recombinant His 6 -vWbp decreased the subsequent adhesion of the WT strain, suggesting competition between bound His 6 -vWbp and subsequently perfused bacterial vWbp. In contrast, the vwb strain showed a mildly increased adhesion when VWF was preperfused with the His 6 -vWbp ( Fig S3D) . Both WT and vwb were found to bind under flow to coated His 6 -vWbp with comparable efficacies (data not shown),
showing that deletion of vwb had no effect on the binding of exogenous vWbp to S. aureus.
Second, we studied whether VWF-vWbp interaction contributes to the adhesion of S.
aureus to collagen, the main subendothelial component. The addition of VWF significantly increased the adhesion of WT ( Fig 1B, Fig S1C) , but had only a limited effect the binding of vwb.
At 1000 s -1 , a large difference in adhesion was observed between the WT and the vwb strains (35,195±6959 AFU vs. 5847±1644 AFU, n=12, P<0.001) (Fig 1B) . Again, addition of exogenous vWbp from WT supernatant or in recombinant form increased the adhesion of vwb (Fig S3A) and WT (Fig S3B) , and the decreased adhesion of the coa/vwb strain was rescued by a plasmid carrying the coa and vwb gene (Fig S2B) .
We further compared the adhesion of the WT and vwb strains to collagen in VWF-deficient plasma, before and after spiking with VWF. When suspended in VWF-deficient plasma, the WT and vwb strains bound comparably to collagen, but VWF repletion only increased the adhesion of the WT strain significantly (Fig 1C) .
S. aureus coagulase activity enhances bacterial adhesion to collagen
Activation of coagulation through coagulase activity is a hallmark of S. aureus. Indeed, in the presence of plasma, we noted a time-dependent formation of microscopic aggregates that facilitated bacterial adhesion to collagen when perfused under flow. To study the interaction between coagulase activity and vWbp-VWF interactions on flow-dependent adhesion, we compared adhesion of S. aureus WT, which possesses 2 coagulases; vwb, which is deficient in vWbp but retains Coa-mediated coagulase-activity; and the coa/vwb strain, which has no detectable coagulase activity.
Preincubation of the WT strain in plasma led to a ~7-fold increase in adhesion for the WT strain (1891±314 AFU vs.13,130±1867 AFU, n≥5, P<0.01) (Fig 2A) (Video 1-2), which could be prevented by the (staphylo)thrombin inhibitor dabigatran. This increased adhesion of the WT strain was parallelled by a deposition of fibrin fibers (Fig 2B) . In contrast, preincubation of the coagulase-deficient coa/vwb strain had only a minor effect on bacterial adhesion (Fig 2A) , and no fibrin formation could be detected (Fig 2B) .
Interestingly, absence of vWbp (vwb strain), which abolished shear-mediated adhesion in the absence of plasma (Fig 1C) , had only a limited effect on adhesion if coagulase-activity was present (Fig 2A) . Although fibrin deposition of vwb was reduced by approximately 80% compared to WT, fibrin fibers could still be detected (Fig 2B) . When absence of vWbp was combined with pharmacological inhibition of coagulase (dabigatran), bacterial adhesion to collagen was completely abrogated (Fig 2A) .
The finding that coagulase activity could promote flow-dependent adhesion of S. aureus independent from vWbp was confirmed by studying adhesion of the coa strain in which the vWbp-prothrombin complex is the only source of staphylothrombin (Fig S4) .
S. aureus-platelet interactions contribute to vessel wall adhesion
Platelets interact with S. aureus via fibrin(ogen) bridges 14 and they also display typical shear-dependent adhesion to VWF 18 . To study the influence of platelet-VWF, platelet-fibrin and platelet-S. aureus 19 interactions on the VWF-dependent adhesion of S. aureus to collagen, perfusion experiments were carried out using both platelet-poor plasma and platelet-rich plasma, spiked with fluorescently labeled bacteria or platelets.
The presence of platelets increased the adhesion of the WT strain to collagen (13,130±1867 AFU vs. 39,504±6431 AFU, n≥11, P<0.01) (Fig 3A) in control conditions. The increased adhesion of S. aureus in the presence of platelets was no longer found when coagulase (Fig 3A) . Interestingly, when the platelet fibrin(ogen)
3 was inhibited by eptifibatide, addition of platelets decreased S. aureus WT adhesion to collagen (Fig 3A) . Finally, the combined inhibition of the coagulase activity of S. aureus and the 3 platelet integrin almost completely abolished bacterial adhesion (39,504±6431 AFU vs. 739±258 AFU, n≥4, P < 0.01) (Fig 3A) .
To explain this, we hypothesized that S. aureus and platelets individually compete for VWF-mediated binding to collagen. However, clustering of bacteria to platelets, which requires coagulase-mediated fibrin formation and subsequent 3 -mediated fibrin bridging 14 , increases the binding capacity. To test this hypothesis, we performed scanning electron microscopy imaging of the coverslips following perfusion, which showed fibrin bridging of bacteria and platelets (Fig 3C-D) . Hence, inhibition or absence of one of these players mitigated the increased bacterial adhesion.
Platelets had less effect on the adhesion of the vwb strain compared to the WT strain, and both eptifibatide and dabigatran further reduced the adhesion of the vwb strain in the presence of platelets (Fig 3A) . The elimination of both vWbp-VWF interactions and staphylothrombinmediated fibrin formation in the coa/vwb strain resulted in a limited adhesion, irrespective of the presence of platelets (Fig 3A) .
The changes in bacterial adhesion were paralleled by changes in platelet deposition on the collagen surface. Absent vWbp reduced platelet adhesion to collagen 2-fold. Adhesion of platelets to collagen was further decreased upon perfusion of coa/vwb (Fig 3B) , underpinning the role of both fibrin generation and vWbp-VWF interactions in the generation of S. aureus-platelet microthrombi.
vWbp binds to VWF via the VWF A1-domain
Neutralization of the VWF A1-domain by a neutralizing anti-A1 mAb reduced bacterial adhesion of S. aureus to collagen (Fig 4A-B) , demonstrating the importance of the A1-domain of VWF for the shear-dependent adhesion of S. aureus to VWF. The impact of the anti-A1 domain was larger in the presence of platelets, which also bind to the VWF A1-domain via the GP1bα receptor.
vWbp enhanced bacterial adhesion to endothelial cells
To investigate the adhesion of S. aureus to ECs under flow, HUVECs were perfused with fluorescently labeled bacteria at 1000 -1 with or without EC activation, which leads to the release For personal use only. on April 13, 2017. by guest www.bloodjournal.org From of VWF (Fig 5A) . Specific VWF staining on activated ECs confirmed release of multimeric VWF (not shown). EC activation and VWF release increased adhesion of the WT strain, which formed typical 'string' patterns of fluorescently labeled bacterial clusters, aligned in the direction of the shear force (Fig 5B) , suggesting the binding of bacteria along a linear-stretched VWF molecule. Compared to WT, vwb adhered 3-fold less (982±207 AFU vs. 305±150 AFU, n≥5, P<0.05) (Fig 5A) . The VWF A1-domain antibody, but not an isotype control antibody, significantly decreased the adhesion of the WT strain to activated ECs (Fig 5A) .
In vivo bacterial adhesion in splanchnic veins is mediated by vWbp-VWF 
143±31.2 AFU, n≥10, P<0.01) (Fig 6A) (Video 5). Inhibition of coagulase activity by dabigatran
reduced the formation and adhesion of aggregates of the WT strain, leading to a large reduction in total bacterial adhesion, but did not prevent the adhesion of individual bacteria (Fig 6A) . When the vwb strain was inoculated along with dabigatran treatment, the combined genetic deletion of vWbp and inhibition of coagulase activity resulted in the strongest reduction in adhesion (WT vs. AFU vs. 14.4±9.01 AFU, n≥13, P < 0.001) (Fig 6A) (Video 6). No further reduction was found when we compared the adhesion of the WT strain with the vwb or the coa/vwb strains to the activated vessel wall of VWF-deficient mice, with or without the inhibition of staphylothrombin.
In conclusion, the absence of both Coa and vWbp or the absence of VWF completely abolished the ability of S. aureus to adhere to the activated vessel wall.
Discussion
In The ability for bacteria to adhere to the vessel wall is a crucial first step to initiate metastatic infections and infective endocarditis 20, 21 . Activation or inflammation of ECs will induce rapid release of highly reactive VWF multimers on the vessel wall. Temporarily retained VWF multimers are a ligand for circulating platelets but also for S. aureus, as recently reported 6, 22 . However, the mechanisms by which S. aureus adheres to VWF under flow conditions remained uncertain.
The ability of S. aureus to bind to VWF had previously been reported to be mediated by the staphylococcal protein A (SpA) 23 . SpA binding to VWF has been documented in static conditions and at low shear stress 24, 25 , however, in high flow, the recruitment of S. aureus to ECs appeared to be SpA-independent 6 . In 2002, vWbp was described as a novel secreted VWFbinding molecule with coagulase activity, present in all tested strains of S. aureus 7 . However, other studies could not confirm VWF as an important ligand for vWbp when assessed in plasma in static conditions 9 .
Our results indicate that vWbp interactions with VWF are enhanced in a flow field. VWF circulates in a compact globular form, but is progressively unfolded in a shear field 26 or when bound to collagen 27, 28 , thereby exposing the VWF A1, A2 and A3-domain. The A1-domain is the ligand-binding site for platelet GPIbα, the major VWF receptor on platelets 29 , whereas the A3-domain is required for VWF binding to collagen fibers. We determined that not only binding of circulating platelets, but also of circulating S. aureus, could largely be blocked by an A1 neutralizing antibody. Hence, S. aureus has developed an adhesion mechanism very similar to that used by platelets.
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From vWbp also interacts with prothrombin to mediate the conversion of soluble fibrinogen into fibrin. S. aureus staphylothrombin activity constitutes an important determinant of bacterial virulence in local abscess formation, sepsis mortality, as well as device-related infections 12, 13, 15 .
Comparing adhesion of the single and double mutants coa, vwb and coa/vwb respectively revealed a unique synergistic action in vessel wall adhesion between coagulation activation and adhesion to VWF. Fibrin clusters bacteria and these aggregates interact with immobilized VWF more effectively than single bacteria. Cluster formation was abolished upon staphylothrombin inhibition by dabigatran or when using the double coa/vwb mutant, in line with our earlier findings 14 .
Platelets rapidly bind to collagen under high shear stress, with VWF acting as a bridging molecule. Our results show that, rather than reducing the adhesion of bacteria by competing for VWF binding, the presence of platelets increased the adhesion of S. aureus to collagen under flow conditions. This increased adhesion in the presence of platelets required both coagulase activity and platelet-fibrin binding through
Fibrin bridges between bacteria and platelets, may facilitate bacterial recruitment and the formation of bacteria-platelet aggregates 14 . We have previously shown that even when staphylothrombin, in contrast to thrombin, does not directly activate the platelet thrombin receptor, S. aureus-mediated fibrin generation indirectly facilitates bacteria-platelet interactions via common interactions with fibrin 14 .
The presence of platelets also increased the adhesion of the vwb mutant. Since this effect was lost in the presence of dabigatran or in the double coa/vwb mutant strain, these findings confirm that the role of platelets in adhesion requires coagulase activity and fibrin formation, even when direct bacterial receptors on platelets have been described 19 . The bacteria-platelet interactions via fibrin may allow bacteria to dock more firmly onto VWF. Platelets will likewise interact with VWF multimers, and use GPIbα-VWF interaction to dock to collagen, further stabilizing adhesion of the conglomerate between bacteria and platelets. When was added where indicated (n≥4). All results are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001. 
